InsiderTrades.com logo
Yours Free! Top FIVE Dividend Stocks Right Now
From The Oxford Club   |   Ad
This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income. 

Click here to get your FREE Ultimate Dividend Package.
>>>

HEM Insider Trading

Insider Ownership Percentage: 11.75%
Insider Buying (Last 12 Months): C$7,400.00
Insider Selling (Last 12 Months): C$0.00

Hemostemix Insider Trading History Chart

This chart shows the insider buying and selling history at Hemostemix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hemostemix Share Price & Price History

Current Price: C$0.12
Price Change: +0.30 (1.20%)
As of 06/7/2023 02:27 PM ET

This chart shows the closing price history over time for HEM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Yours Free! Top FIVE Dividend Stocks Right Now
From The Oxford Club   |   Ad
This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income. 

Click here to get your FREE Ultimate Dividend Package.
>>>

Hemostemix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/30/2023Thomas SmeenkDirectorBuy20,000C$0.22C$4,400.001,279,125
10/24/2022Thomas SmeenkDirectorBuy20,000C$0.15C$3,000.001,189,125
5/4/2022Thomas SmeenkDirectorBuy20,000C$0.30C$6,000.001,169,125
4/18/2022Thomas SmeenkDirectorSell300,000C$0.31C$93,210.001,149,125
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for Hemostemix (CVE:HEM)

Hemostemix logo
Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Read More on Hemostemix

Today's Range

Now: C$0.12
Low: C$0.11
High: C$0.12

50 Day Range

MA: C$0.15
Low: C$0.12
High: C$0.18

52 Week Range

Now: C$0.12
Low: C$0.11
High: C$0.38

Volume

28,000 shs

Average Volume

67,333 shs

Market Capitalization

C$9.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Who are the company insiders with the largest holdings of Hemostemix?

Hemostemix's top insider shareholders include:
  1. Thomas Smeenk (Director)
Learn More about top insider investors at Hemostemix.
Yours Free! Top FIVE Dividend Stocks Right Now
From The Oxford Club   |   Ad
This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income. 

Click here to get your FREE Ultimate Dividend Package.
>>>